Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US based molecular medicine company Theranostics Health has appointed Danong Chen as the new president and CEO.
Subscribe to our email newsletter
Dr Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company which was acquired by Genentech in 2007. Dr Chen holds a PhD from Baylor College of Medicine in Houston, Texas as well as an MBA from Arthur D Little School of Management in Boston, Massachusetts.
James Cooper, the chairman of the board of Theranostics, said: “We strongly believe that Danong’s impressive scientific and business credentials combined with her proven management and leadership skills will enable Theranostics Health to achieve its true potential in the years ahead.”